Director’s Innovation Speaker Series: Beyond FDA Approval: Assessing the Value of New Health Technologies
Foluso Agboola, MBBS, MPH provided a brief background on the Institute for Clinical and Economic Review (ICER) and described the Value Assessment Framework (i.e., the conceptual framework and set of associated methods that guide the development of ICER’s evidence reports) using their review of esketamine for treatment-resistant depression as an example. Dr. Agboola also provided examples of how ICER’s work is applied in the real world.
About Dr. Agboola
Dr. Agboola is the Vice President of Research at ICER. This independent non-profit research institute generates evidence on the effectiveness and value of drugs and other medical services.
About the Director’s Innovation Speaker Series
The National Institute of Mental Health (NIMH) established the Director’s Innovation Speaker Series to encourage broad, interdisciplinary thinking in the development of scientific initiatives and programs, and to press for theoretical leaps in science over the continuation of incremental thought. Innovation speakers are encouraged to describe their work from the perspective of breaking through existing boundaries and developing successful new ideas, as well as working outside their primary area of expertise in ways that have pushed their fields forward. We encourage discussions of the meaning of innovation, creativity, breakthroughs, and paradigm-shifting.
Division of Extramural Activities